| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |